139 related articles for article (PubMed ID: 10897013)
1. Cancer risk and mortality in users of calcium channel blockers. A cohort study.
Sørensen HT; Olsen JH; Mellemkjaer L; Marie A; Steffensen FH; McLaughlin JK; Baron JA
Cancer; 2000 Jul; 89(1):165-70. PubMed ID: 10897013
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.
Friis S; Sørensen HT; Mellemkjaer L; McLaughlin JK; Nielsen GL; Blot WJ; Olsen JH
Cancer; 2001 Nov; 92(9):2462-70. PubMed ID: 11745304
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in users of calcium channel blockers.
Olsen JH; Sørensen HT; Friis S; McLaughlin JK; Steffensen FH; Nielsen GL; Andersen M; Fraumeni JF; Olsen J
Hypertension; 1997 May; 29(5):1091-4. PubMed ID: 9149671
[TBL] [Abstract][Full Text] [Related]
4. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
Sørensen HT; Mellemkjaer L; Olsen JH
Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
[TBL] [Abstract][Full Text] [Related]
5. A cohort study of antihypertensive medication use and breast cancer among Danish women.
Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
[TBL] [Abstract][Full Text] [Related]
6. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Cancer; 1997 Oct; 80(8):1438-47. PubMed ID: 9338468
[TBL] [Abstract][Full Text] [Related]
7. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.
Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
BMC Neurol; 2015 Mar; 15():24. PubMed ID: 25884780
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study.
Friis S; Nielsen GL; Mellemkjaer L; McLaughlin JK; Thulstrup AM; Blot WJ; Lipworth L; Vilstrup H; Olsen JH
Int J Cancer; 2002 Jan; 97(1):96-101. PubMed ID: 11774249
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
[TBL] [Abstract][Full Text] [Related]
10. Calcium-channel blockers and risk of cancer.
Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
[TBL] [Abstract][Full Text] [Related]
11. Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality: A Population-based Cohort Study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Epidemiology; 2018 May; 29(3):407-413. PubMed ID: 29608546
[TBL] [Abstract][Full Text] [Related]
12. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
13. Inverse association between prostate cancer and the use of calcium channel blockers.
Debes JD; Roberts RO; Jacobson DJ; Girman CJ; Lieber MM; Tindall DJ; Jacobsen SJ
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):255-9. PubMed ID: 14973089
[TBL] [Abstract][Full Text] [Related]
14. Calcium-channel blockade and incidence of cancer in aged populations.
Pahor M; Guralnik JM; Ferrucci L; Corti MC; Salive ME; Cerhan JR; Wallace RB; Havlik RJ
Lancet; 1996 Aug; 348(9026):493-7. PubMed ID: 8757150
[TBL] [Abstract][Full Text] [Related]
15. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study.
Engeland A; Skurtveit S; Mørland J
Ann Epidemiol; 2007 Aug; 17(8):597-602. PubMed ID: 17574863
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive drugs and the risk of incident rosacea.
Spoendlin J; Voegel JJ; Jick SS; Meier CR
Br J Dermatol; 2014 Jul; 171(1):130-6. PubMed ID: 24428524
[TBL] [Abstract][Full Text] [Related]
17. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive drugs and the risk of idiopathic aplastic anaemia.
Myers MW; Vasilakis C; Kaufman MR; Jick H
Br J Clin Pharmacol; 2000 Jun; 49(6):604-8. PubMed ID: 10848725
[TBL] [Abstract][Full Text] [Related]
19. Cellular telephones and cancer--a nationwide cohort study in Denmark.
Johansen C; Boice J; McLaughlin J; Olsen J
J Natl Cancer Inst; 2001 Feb; 93(3):203-7. PubMed ID: 11158188
[TBL] [Abstract][Full Text] [Related]
20. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.
Ruths S; Bakken MS; Ranhoff AH; Hunskaar S; Engesæter LB; Engeland A
BMC Geriatr; 2015 Dec; 15():153. PubMed ID: 26626043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
